Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 6/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18148986 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL3960941 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL149866 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL640855 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL672723 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL673378 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL673380 | 0.96 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL9622651 | 0.93 | CYP3A4 (0.46) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL3967221 | 0.90 | CYP3A4 (0.50) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 | |
| SCHEMBL673441 | 0.86 | CYP3A4 (0.50) | CYP3A4L3MBTL1CA2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10035908-B1 | Process for preparing blends of trans-1,4-polybutadiene and syndiotactic 1,2-polybutadiene | BRIDGESTONE CORPORATION (JP) | 2018-07-31 | — | — | US | disclosed |
| EP-1476480-B1 | POLYMERIZATION PROCESS FOR PREPARING SYNDIOTACTIC 1,2-POLYBUTADIENE | BRIDGESTONE CORP (JP) | 2009-07-22 | — | — | EP | disclosed |
| EP-1419182-B1 | IRON-BASED CATALYST COMPOSITION FOR THE MANUFACTURE OF SYNDIOTACTIC 1,2-POLYBUTADIENE | BRIDGESTONE CORP (JP) | 2008-10-15 | — | — | EP | disclosed |
| US-6720397-B2 | Using supersaturation solutiton and iron coordination catalyst | BRIDGESTONE CORPORATION (JP) | 2004-04-13 | — | — | US | disclosed |
| US-6627712-B2 | Reaction product of an iron-containing compound, a silyl phosphonate, and an organoaluminum compound to polymerize 1,3-butadiene into syndiotactic 1,2-polybutadiene | BRIDGESTONE CORPORATION (JP) | 2003-09-30 | — | — | US | disclosed |
| US-6610804-B2 | An iron compound, an alpha-acylphosphonate diester, and an organoaluminum compound | BRIDGESTONE CORPORATION (JP) | 2003-08-26 | — | — | US | disclosed |
| US-20030073790-A1 | Iron-based catalyst composition for the manufacture of syndiotactic 1, 2-polybutadiene | BRIDGESTONE CORP. | 2003-04-17 | — | — | US | disclosed |
| US-20020156210-A1 | Manufacture of conjugated diene polymers by using an iron-based catalyst composition | BRIDGESTONE CORP. | 2002-10-24 | — | — | US | disclosed |
| WO-2002066554-A1 | MANUFACTURE OF BLENDS OF SYNDIOTACTIC 1,2-POLYBUTADIENE AND RUBBERY ELASTOMERS | BRIDGESTONE CORPORATION (JP) | 2002-08-29 | — | — | WO | disclosed |
| US-6433237-B1 | USING COORDINATION CATALYST | BRIDGESTONE CORPORATION (JP) | 2002-08-13 | — | — | US | disclosed |
| US-6320004-B1 | FORMED BY COMBINING (A) A IRON-CONTAINING COMPOUND; (B) AN ORGANOMAGNESIUM COMPOUND; AND (C) A SILYL PHOSPHONATE; POLYMERIZING CONJUGATED DIENE MONOMERS | BRIDGESTONE CORPORATION (JP) | 2001-11-20 | — | — | US | disclosed |